StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

Vycor Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Vycor Medical's ebitda for the twelve months ending Jun 30, 2026 was $106.84K, up 30.2% year over year. For fiscal 2025 it was $93.42K, up 85.4% from the year before. The highest annual figure on record is $97.69K in fiscal 2023.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$93.42K+85.4%
FY2024Dec 31, 2024$50.38K-48.4%
FY2023Dec 31, 2023$97.69K–
FY2022Dec 31, 2022-$248.28K–
FY2021Dec 31, 2021-$369.88K–
FY2020Dec 31, 2020-$670.87K–
FY2019Dec 31, 2019-$541.52K–
FY2018Dec 31, 2018-$1.15M–
FY2017Dec 31, 2017-$1.04M–
FY2016Dec 31, 2016-$1.33M–
FY2015Dec 31, 2015-$1.63M–
FY2014Dec 31, 2014-$2.36M–
FY2013Dec 31, 2013-$1.93M–
FY2012Dec 31, 2012-$2.47M–
FY2011Dec 31, 2011-$4.42M–
FY2010Dec 31, 2010-$1.88M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$21.73K-67.1%
Q1 FY2026Mar 31, 2026$59.79K+2782.7%
Q4 FY2025Dec 31, 2025-$21.65K-163.2%
Q3 FY2025Sep 30, 2025$46.97K–
Q2 FY2025Jun 30, 2025$66.03K+112.6%
Q1 FY2025Mar 31, 2025$2.07K-61.2%
Q4 FY2024Dec 31, 2024$34.22K–
Q3 FY2024Sep 30, 2024-$20.26K–
Q2 FY2024Jun 30, 2024$31.06K-72.0%
Q1 FY2024Mar 31, 2024$5.35K-88.8%
Q4 FY2023Dec 31, 2023-$49.69K–
Q3 FY2023Sep 30, 2023-$11.10K–
Q2 FY2023Jun 30, 2023$110.89K–
Q1 FY2023Mar 31, 2023$47.58K–
Q4 FY2022Dec 31, 2022-$76.82K–
Q3 FY2022Sep 30, 2022-$73.49K–
Q2 FY2022Jun 30, 2022-$59.73K-245.3%
Q1 FY2022Mar 31, 2022-$38.25K–
Q4 FY2021Dec 31, 2021-$147.40K–
Q3 FY2021Sep 30, 2021-$70.67K–
Q2 FY2021Jun 30, 2021$41.09K–
Q1 FY2021Mar 31, 2021-$192.90K–
Q4 FY2020Dec 31, 2020-$162.22K–
Q3 FY2020Sep 30, 2020-$191.88K–
Q2 FY2020Jun 30, 2020-$184.72K–
Q1 FY2020Mar 31, 2020-$132.04K–
Q4 FY2019Dec 31, 2019-$160.61K–
Q3 FY2019Sep 30, 2019-$150.45K–
Q2 FY2019Jun 30, 2019-$115.77K–
Q1 FY2019Mar 31, 2019-$147.75K–
Q4 FY2018Dec 31, 2018-$426.75K–
Q3 FY2018Sep 30, 2018-$89.73K–
Q2 FY2018Jun 30, 2018-$362.32K–
Q1 FY2018Mar 31, 2018-$272.55K–
Q4 FY2017Dec 31, 2017-$299.31K–
Q3 FY2017Sep 30, 2017-$222.87K–
Q2 FY2017Jun 30, 2017-$284.63K–
Q1 FY2017Mar 31, 2017-$230.35K–
Q4 FY2016Dec 31, 2016-$405.69K–
Q3 FY2016Sep 30, 2016-$251.43K–

More Vycor Medical figures

See a number that looks wrong?